Clinical Trial Update: Euglycemic Clamp Study Comparing Two New Insulin Glargine Formulations in Subjects With Type 1 Diabetes Mellitus [Phase 1]

View source ↗

Summary

A phase 1 euglycemic clamp study comparing two insulin glargine formulations in adults with Type 1 diabetes was completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine Formulation A (insulin glargine)
• Insulin Glargine Formulation B (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Type1 Diabetes | Phase 1 | Status: COMPLETED